drugset / Trial / NCT01127646
A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents
Non-randomizedParallel-groupTriple-blindTreatment
Summary
The main purpose of the study is to help to understand the effect on children and adolescents who are stable on treatment with atomoxetine or osmotic-release oral system (OROS) methylphenidate for attention-deficit/hyperactivity disorder (ADHD) of not taking the medication for a maximum of 6 days over a 28-day study treatment period.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 25 mg | Oral |
| Subject | Atomoxetine | Other / unclassified | 80 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 18 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 54 mg | Oral |